A Novel Melanoma Vaccine Based on a Shared Neoantigen and a Liquid Polymer Platform

Project: Research project

Project Details

Description

A Novel Melanoma Vaccine Based on a Shared Neoantigen and a Liquid Polymer Platform
StatusActive
Effective start/end date3/1/232/28/25

Funding

  • TREKKA THERAPEUTICS, LLC
  • NATIONAL INSTITUTES OF HEALTH (NIH)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.